A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly

Overview

Journal Clin Interv Aging

Publisher Dove Medical Press

Specialty Geriatrics

Date 2020 Mar 19

PMID 32184579

Citations 6

Authors

Pi-Shan Hsu

Ie-Bin Lian

Day-Yu Chao

Affiliations

Soon will be listed here.

Abstract

Background: Influenza is a major cause of morbidity and mortality in the elderly worldwide. Influenza vaccination can prevent morbidity/mortality from influenza infection. A gap of 1-2 years, before an epidemic strain is recommended by the World Health Organization (WHO) to be the vaccine strain in Southeast Asia, has been reported; this results in a high rate of vaccine mismatch and excess influenza-associated morbidity. The aim of the current study was to evaluate the effect of repeated vaccination on vaccine effectiveness (VE) among the elderly in Taiwan, during years with and without early appearance of antigenically drifted strains.

Methods: A historical cohort study was conducted to evaluate the impact of repeated vaccination on the reduction of influenza-associated hospitalization among persons older than 64 years over two influenza seasons: 2007-08, with all circulating virus strains mismatched, and 2008-09, with all virus strains matched with the vaccine strains, considering four exposure effects, namely current vaccine effect, sequential vaccination effect, residual protection effect and no vaccination effect. Propensity score matching on vaccination status was performed to ensure similar baseline characteristics between the groups that received and did not receive vaccination.

Results: Only current-year vaccination in combination with prior history of annual revaccination significantly reduced the risk of hospitalization, with adjusted hazard ratios of 0.68 (95% CI: 0.54, 0.85) and 0.74 (95% CI: 0.57, 0.95) during the 2007-08 and 2008-09 influenza seasons, respectively. Further stratification showed that even during the 2007-08 influenza season, when all vaccinations were mismatched with the circulating strains, sequential vaccinations still significantly reduced influenza-associated hospitalization in the female population aged 68-74 and 75-84 years, with adjusted VE of 25.2% (95% CI: -9.6, 49.0%) and 36.9% (95% CI: 17.1, 52.0%), respectively.

Conclusion: Our study supports the recommendation of annual revaccination against influenza in the elderly, even though the circulating strain of influenza virus was antigenically mismatched with the vaccine strains.

Citing Articles

Can propensity score matching replace randomized controlled trials?.

Liau M, Toh E, Muhamed S, Selvakumar S, Shelat V World J Methodol. 2024; 14(1):90590.

PMID: 38577204 PMC: 10989411. DOI: 10.5662/wjm.v14.i1.90590.

[Once vaccinated, always vaccinated? A claims data analysis on repeated influenza vaccinations among individuals aged ≥ 60 years].

Storch J, Meissner F, Bode M, Kwetkat A, Pletz M, Freytag A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023; 66(9):953-961.

PMID: 37291252 PMC: 10249936. DOI: 10.1007/s00103-023-03716-1.

Repeated influenza vaccination and hospitalization outcomes among older patients with cardiovascular or respiratory diseases.

Pang Y, Yu M, Lv M, Lu M, Wu J, Xie Z Hum Vaccin Immunother. 2022; 17(12):5522-5528.

PMID: 35133241 PMC: 8903947. DOI: 10.1080/21645515.2021.2007012.

Influence of Prior Influenza Vaccination on Current Influenza Vaccine Effectiveness in Children Aged 1 to 5 Years.

Matsumoto K, Fukushima W, Morikawa S, Fujioka M, Matsushita T, Kubota M Vaccines (Basel). 2021; 9(12).

PMID: 34960193 PMC: 8706378. DOI: 10.3390/vaccines9121447.

Influenza vaccination coverage in elderly and high-risk adults: characterization of associated factors.

Meneghini K, Hood C, Menezes L, Mendoza-Sassi R, Dumith S Einstein (Sao Paulo). 2021; 19:eAO5830.

PMID: 34231825 PMC: 8244927. DOI: 10.31744/einstein_journal/2021AO5830.

References

Ohmit S, Petrie J, Malosh R, Cowling B, Thompson M, Shay D . Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013; 56(10):1363-9. PMC: 3693492. DOI: 10.1093/cid/cit060. View

Monto A, Petrie J, Cross R, Johnson E, Liu M, Zhong W . Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. J Infect Dis. 2015; 212(8):1191-9. DOI: 10.1093/infdis/jiv195. View

Klein S, Marriott I, Fish E . Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015; 109(1):9-15. PMC: 4447843. DOI: 10.1093/trstmh/tru167. View

Petrie J, Ohmit S, Johnson E, Truscon R, Monto A . Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. J Infect Dis. 2015; 212(12):1914-22. PMC: 4655854. DOI: 10.1093/infdis/jiv313. View

Fiore A, Bridges C, Cox N . Seasonal influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:43-82. DOI: 10.1007/978-3-540-92165-3_3. View

Furman D, Hejblum B, Simon N, Jojic V, Dekker C, Thiebaut R . Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination. Proc Natl Acad Sci U S A. 2013; 111(2):869-74. PMC: 3896147. DOI: 10.1073/pnas.1321060111. View

Belongia E, Skowronski D, McLean H, Chambers C, Sundaram M, De Serres G . Repeated annual influenza vaccination and vaccine effectiveness: review of evidence. Expert Rev Vaccines. 2017; 16(7):1-14. DOI: 10.1080/14760584.2017.1334554. View

McLean H, Thompson M, Sundaram M, Meece J, McClure D, Friedrich T . Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014; 59(10):1375-85. PMC: 4207422. DOI: 10.1093/cid/ciu680. View

Ohmit S, Petrie J, Malosh R, Fry A, Thompson M, Monto A . Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. J Infect Dis. 2014; 211(10):1519-28. PMC: 4462665. DOI: 10.1093/infdis/jiu650. View

10.

Thompson W, Shay D, Weintraub E, Brammer L, Cox N, Anderson L . Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003; 289(2):179-86. DOI: 10.1001/jama.289.2.179. View

11.

Miller M, Gardner T, Krammer F, Aguado L, Tortorella D, Basler C . Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis. Sci Transl Med. 2013; 5(198):198ra107. PMC: 4091683. DOI: 10.1126/scitranslmed.3006637. View

12.

Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barbera J, Gefenaite G . Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Vaccine. 2017; 35(34):4298-4306. DOI: 10.1016/j.vaccine.2017.06.088. View

13.

Belongia E, Simpson M, King J, Sundaram M, Kelley N, Osterholm M . Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016; 16(8):942-51. DOI: 10.1016/S1473-3099(16)00129-8. View

14.

Sullivan S, Kelly H . Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis. 2013; 57(3):474-6. DOI: 10.1093/cid/cit255. View

15.

Russell C, Jones T, Barr I, Cox N, Garten R, Gregory V . Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine. 2009; 26 Suppl 4:D31-4. DOI: 10.1016/j.vaccine.2008.07.078. View

16.

van Essen G, Kuyvenhoven M, de Melker R . Why do healthy elderly people fail to comply with influenza vaccination?. Age Ageing. 1997; 26(4):275-9. DOI: 10.1093/ageing/26.4.275. View

17.

Shih S, Chen G, Yang C, Yang W, Liu D, Lin J . Laboratory-based surveillance and molecular epidemiology of influenza virus in Taiwan. J Clin Microbiol. 2005; 43(4):1651-61. PMC: 1081360. DOI: 10.1128/JCM.43.4.1651-1661.2005. View

18.

Wang S, Lee Y, Chan Y, Liu H, Yen Y, Liu W . Influenza A virus in Taiwan, 1980-2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene. J Med Virol. 2009; 81(8):1457-70. PMC: 7166446. DOI: 10.1002/jmv.21531. View

19.

Minney-Smith C, Selvey L, Levy A, Smith D . Post-pandemic influenza A/H1N1pdm09 is associated with more severe outcomes than A/H3N2 and other respiratory viruses in adult hospitalisations. Epidemiol Infect. 2019; 147:e310. PMC: 7003621. DOI: 10.1017/S095026881900195X. View

20.

Cox N, Subbarao K . Global epidemiology of influenza: past and present. Annu Rev Med. 2000; 51:407-21. DOI: 10.1146/annurev.med.51.1.407. View